Tivorsan Pharmaceuticals
closed- Tivorsan Pharmaceuticals.
Launch date
Employees
Market cap
-
Enterprise valuation
€4—5m (Dealroom.co estimates Jan 2012.)
Providence Rhode Island (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $1.1m | Early VC | |
$1.0m | Seed | ||
N/A | $2.8m | Early VC | |
N/A | $1.6m | Early VC | |
N/A | $1.8m | Early VC | |
N/A | $4.5m | Early VC | |
Total Funding | €11.6m |
Related Content
Recent News about Tivorsan Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.